In prostate cancer cells, NFκB may promote cell growth and proliferation by regulating expression of genes such as c-myc, cyclin D1, and IL-6 [66,69], and inhibit apoptosis through activation of expression of anti-apoptotic genes, such as Bcl-2 and Bcl-XL. This evidence concerns the gene CCND1 and prostate cancer.